Thanks Aiming. I hope this poll sends a message to Varney that he can't continue diluting without delivering on a pharma deal. And if a decent pharma deal isn't possible, he's going to have to sell the company to the highest bidder, because his 'credit card' is being taken away.
The Federal Reserve may be able to get away with a perpetual printing press, but the biotech version of that process can be stopped by a shareholder vote.
Market Data 
Markets 
AI
